Venture Beat published an article discussing the acceleration of data, technology, and human capability. The article examined the future of bio-tech and GC was recognized as a leader in the field.
The re-emergence of BioTech, or BioTech 2.0, is a great example of innovation in automating procedures on top of newly procured datasets. Companies like Transcriptic are making robotic fully automated wet labs while TeselaGen and Genome Compiler are providing CAD and CAM tools for biologists. We aren’t far from a day when biologists are fully removed from pipettes and traditional lab work. The next generation of biologists may well use programmatic interfaces and abstracted models as computational biology envelopes the entirety of biology — driving what has traditionally been an analytic truth seeking expedition to a high throughput low latency synthetic data science. (Zavain Dar)
Read the article here